SCHEMBL30304105

SCHEMBL30304105

COC(=O)CCCCCCCC=CCC=CCCCCCc1cccc(CCCCCC=CCC=CCCCCCCCC(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 5/20 0.53
▸ ALDH1A1 P00352 7/20 0.49
▸ F7 P08709 5/20 0.49
▸ F3 P13726 5/20 0.49
▸ PPARG P37231 4/20 0.49
▸ CYP19A1 P11511 3/20 0.49
▸ PPARD Q03181 3/20 0.49
▸ MAPT P10636 3/20 0.49
▸ OXER1 Q8TDS5 2/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ FFAR1 O14842 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ ALOX15 P16050 2/20 0.49
▸ PTGS1 P23219 2/20 0.49
▸ FFAR4 Q5NUL3 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ DUSP3 P51452 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30457561 0.90 MAPT (0.60) PPARAALDH1A1F7F3PPARG
SCHEMBL10993370 0.86 EPHX2 (0.54) ALDH1A1MAPTLMNARXFP1EPHX2
SCHEMBL10993373 0.86 EPHX2 (0.54) ALDH1A1MAPTLMNARXFP1EPHX2
SCHEMBL6758781 0.82 EPHX2 (0.52) MAPTLMNARXFP1EPHX2FAAH
SCHEMBL6758777 0.82 EPHX2 (0.52) MAPTLMNARXFP1EPHX2FAAH
SCHEMBL23925403 0.80 TSHR (0.67) PPARAALDH1A1F7F3PPARG
SCHEMBL11443984 0.80 TSHR (0.67) PPARAALDH1A1F7F3PPARG
SCHEMBL11437841 0.80 TSHR (0.67) PPARAALDH1A1F7F3PPARG
SCHEMBL23925457 0.80 TSHR (0.67) PPARAALDH1A1F7F3PPARG
SCHEMBL23925402 0.80 TSHR (0.67) PPARAALDH1A1F7F3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4402121-A1 ACYCLIC LIPIDS AND METHODS OF USE THEREOF Renagade Therapeutics Management Inc. (US) 2024-07-24 — — EP disclosed
WO-2023044343-A1 ACYCLIC LIPIDS AND METHODS OF USE THEREOF RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2023-03-23 — — WO disclosed
Send feedback